FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

30883611000001109: Rivastigmine 4.5mg capsules (Mawdsley-Brooks & Company Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-Nov 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
95493501000001119 Rivastigmine 4.5mg capsules (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
95493601000001115 Rivastigmine 4.5mg capsules (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rivastigmine 4.5mg capsules (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rivastigmine 4.5mg capsules (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rivastigmine 4.5mg capsules (Mawdsley-Brooks & Company Ltd) Is a Product containing precisely rivastigmine (as rivastigmine tartrate) 4.5 milligram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Rivastigmine 4.5mg capsules (Mawdsley-Brooks & Company Ltd) Has active ingredient Rivastigmine tartrate false Inferred relationship Existential restriction modifier
Rivastigmine 4.5mg capsules (Mawdsley-Brooks & Company Ltd) Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
Rivastigmine 4.5mg capsules (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rivastigmine 4.5mg capsules (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rivastigmine 4.5mg capsules (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Rivastigmine tartrate true Inferred relationship Existential restriction modifier
Rivastigmine 4.5mg capsules (Mawdsley-Brooks & Company Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Rivastigmine 4.5mg capsules (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Rivastigmine true Inferred relationship Existential restriction modifier
Rivastigmine 4.5mg capsules (Mawdsley-Brooks & Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rivastigmine 4.5mg capsules (Mawdsley-Brooks & Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Rivastigmine 4.5mg capsules (Mawdsley-Brooks & Company Ltd) Has basis of strength substance Rivastigmine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Rivastigmine 4.5mg capsules (Mawdsley-Brooks & Company Ltd) 28 capsule Has AMP True Rivastigmine 4.5mg capsules (Mawdsley-Brooks & Company Ltd) Inferred relationship Existential restriction modifier
Rivastigmine 4.5mg capsules (Mawdsley-Brooks & Company Ltd) 56 capsule Has AMP True Rivastigmine 4.5mg capsules (Mawdsley-Brooks & Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start